Dec 11, 2017 04:10 PM

Quick Take: BGI Genomics Partners With Traditional Chinese Medicine Supplier

Photo: Visual China
Photo: Visual China

Chinese genome giant BGI Genomics Co. Ltd. has expanded into a new business: helping to standardize and modernize traditional Chinese medicine (TCM).

BGI has agreed to set up a joint venture with Kangmei Pharmaceutical Co. Ltd., a TCM developer that cultivates several herb plantations in China, the companies announced Friday.

Kangmei Pharma will contribute 95% of the $7.5 million project’s funding, while BGI will provide devices and technology. A Kangmei representative told Caixin that the drugmaker wants to grasp a better understanding of herbs to control TCM quality and improve its efficacy.

You've accessed an article available only to subscribers
Share this article
Open WeChat and scan the QR code
Copyright © 2017 Caixin Global Limited. All Rights Reserved.